Allos Therapeutics Inc
2 known investors
Find your way into Allos Therapeutics Inc
Sign up to see every warm intro you have to Allos Therapeutics Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Allos Therapeutics Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Allos uses causal AI modeling to optimize pharmaceutical drug formulation and reformulation, mapping chemistry, process variables, and performance data to reduce failed experiments and shorten timelines. It serves innovator and generic drug companies, coordinating CROs and CDMOs to take a molecule from modeling through manufacturing.
Investors · 2
Frequently asked questions
- What does Allos Therapeutics Inc do?
- Allos uses causal AI modeling to optimize pharmaceutical drug formulation and reformulation, mapping chemistry, process variables, and performance data to reduce failed experiments and shorten timelines. It serves innovator and generic drug companies, coordinating CROs and CDMOs to take a molecule from modeling through manufacturing.
- Who are Allos Therapeutics Inc's investors?
- Allos Therapeutics Inc's investors include Oak Investment Partners, SV Health Investors.
